MAZE vs POOL · $525.3M cap vs P/E 18, rev $5.31B
Maze Therapeutics, Inc. Common Stock (MAZE) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
MAZE currently screens at market cap $525.3M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the MAZE and POOL stock pages for the full models.
Not investment advice.